UBS Group’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,221
| Closed | -$1.61K | – | 9378 |
|
|
2024
Q3 | $1.61K | Buy |
1,221
+1,121
| +1,121% | +$1.48K | ﹤0.01% | 7379 |
|
|
2024
Q2 | $760 | Hold |
100
| – | – | ﹤0.01% | 7616 |
|
|
2024
Q1 | $900 | Hold |
100
| – | – | ﹤0.01% | 7141 |
|
|
2023
Q4 | $1.07K | Sell |
100
-579
| -85% | -$6.21K | ﹤0.01% | 7195 |
|
|
2023
Q3 | $4.08K | Buy |
679
+178
| +36% | +$1.07K | ﹤0.01% | 6334 |
|
|
2023
Q2 | $3.46K | Buy |
501
+298
| +147% | +$2.06K | ﹤0.01% | 6545 |
|
|
2023
Q1 | $3.18K | Sell |
203
-35
| -15% | -$549 | ﹤0.01% | 7262 |
|
|
2022
Q4 | $4.76K | Sell |
238
-594
| -71% | -$11.9K | ﹤0.01% | 8081 |
|
|
2022
Q3 | $15K | Sell |
832
-7,483
| -90% | -$135K | ﹤0.01% | 6755 |
|
|
2022
Q2 | $184K | Buy |
8,315
+7,751
| +1,374% | +$172K | ﹤0.01% | 4017 |
|
|
2022
Q1 | $16K | Sell |
564
-675
| -54% | -$19.1K | ﹤0.01% | 6729 |
|
|
2021
Q4 | $56K | Sell |
1,239
-7,066
| -85% | -$319K | ﹤0.01% | 5714 |
|
|
2021
Q3 | $692K | Buy |
8,305
+1,183
| +17% | +$98.6K | ﹤0.01% | 3516 |
|
|
2021
Q2 | $677K | Buy |
7,122
+6,958
| +4,243% | +$661K | ﹤0.01% | 3540 |
|
|
2021
Q1 | $27K | Buy |
+164
| New | +$27K | ﹤0.01% | 6097 |
|
|
2020
Q4 | – | Sell |
-193
| Closed | -$7K | – | 7745 |
|
|
2020
Q3 | $7K | Buy |
+193
| New | +$7K | ﹤0.01% | 6274 |
|
|
2020
Q2 | – | Sell |
-5
| Closed | – | – | 7405 |
|
|
2020
Q1 | $0 | Sell |
5
-16
| -76% | – | ﹤0.01% | 7316 |
|
|
2019
Q4 | $1K | Sell |
21
-60
| -74% | -$2.86K | ﹤0.01% | 6916 |
|
|
2019
Q3 | $8K | Sell |
81
-11
| -12% | -$1.09K | ﹤0.01% | 6332 |
|
|
2019
Q2 | $13K | Buy |
92
+57
| +163% | +$8.05K | ﹤0.01% | 6037 |
|
|
2019
Q1 | $6K | Sell |
35
-41
| -54% | -$7.03K | ﹤0.01% | 6276 |
|
|
2018
Q4 | $8K | Buy |
76
+27
| +55% | +$2.84K | ﹤0.01% | 6443 |
|
|
2018
Q3 | $11K | Buy |
49
+41
| +513% | +$9.2K | ﹤0.01% | 6212 |
|
|
2018
Q2 | $18K | Buy |
8
+3
| +60% | +$6.75K | ﹤0.01% | 5867 |
|
|
2018
Q1 | $11K | Sell |
5
-4
| -44% | -$8.8K | ﹤0.01% | 5937 |
|
|
2017
Q4 | $17K | Buy |
9
+4
| +80% | +$7.56K | ﹤0.01% | 5718 |
|
|
2017
Q3 | $5K | Hold |
5
| – | – | ﹤0.01% | 6325 |
|
|
2017
Q2 | $3K | Sell |
5
-17
| -77% | -$10.2K | ﹤0.01% | 6360 |
|
|
2017
Q1 | $15K | Buy |
22
+1
| +5% | +$682 | ﹤0.01% | 5436 |
|
|
2016
Q4 | $15K | Buy |
21
+16
| +320% | +$11.4K | ﹤0.01% | 5739 |
|
|
2016
Q3 | $5K | Hold |
5
| – | – | ﹤0.01% | 6209 |
|
|
2016
Q2 | $4K | Hold |
5
| – | – | ﹤0.01% | 6347 |
|
|
2016
Q1 | $3K | Sell |
5
-1
| -17% | -$600 | ﹤0.01% | 6347 |
|
|
2015
Q4 | $6K | Buy |
6
+1
| +20% | +$1K | ﹤0.01% | 6277 |
|
|
2015
Q3 | $5K | Hold |
5
| – | – | ﹤0.01% | 6303 |
|
|
2015
Q2 | $9K | Sell |
5
-13
| -72% | -$23.4K | ﹤0.01% | 6040 |
|
|
2015
Q1 | $17K | Buy |
18
+8
| +80% | +$7.56K | ﹤0.01% | 5517 |
|
|
2014
Q4 | $11K | Buy |
+10
| New | +$11K | ﹤0.01% | 5965 |
|